Autor: |
Jesse J, Fryk, Denese C, Marks, Jody, Hobson-Peters, Daniel, Watterson, Roy A, Hall, Paul R, Young, Stefan, Reichenberg, Frank, Tolksdorf, Chryslain, Sumian, Ute, Gravemann, Axel, Seltsam, Helen M, Faddy |
Rok vydání: |
2017 |
Předmět: |
|
Zdroj: |
Transfusion. 57(11) |
ISSN: |
1537-2995 |
Popis: |
Zika virus (ZIKV) has emerged as a potential threat to transfusion safety worldwide. Pathogen inactivation is one approach to manage this risk. In this study, the efficacy of the THERAFLEX UV-Platelets system and THERAFLEX MB-Plasma system to inactivate ZIKV in platelet concentrates (PCs) and plasma was investigated.PCs spiked with ZIKV were treated with the THERAFLEX UV-Platelets system at 0.05, 0.10, 0.15, and 0.20 J/cmTreatment of PCs with THERAFLEX UV-Platelets system resulted in a mean of 5 log reduction in ZIKV infectivity at the standard UVC dose (0.20 J/cmOur study demonstrates that the THERAFLEX UV-Platelets system and THERAFLEX MB-Plasma system can reduce ZIKV infectivity in PCs and pooled plasma to the detection limit of the assays used. These findings suggest both systems have the capacity to be an effective option to manage potential ZIKV transfusion transmission risk. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|